Inventor · disambiguated record
Diva Sze-Ming Chan
Also filed as: CHAN DIVA · CHAN DIVA SZE-MING
12 granted patents·22 pending applications·411 citations·filing 2005–2022
94Inventor score
Top patents by PatentIndex Score
34 records- 0198US7579473B2c-Met modulators and methods of useEXELIXIS INC·Filed 2009·Granted Aug 25, 2009·95 cites·7 claims
- 0297US8497284B2C-met modulators and method of useBANNEN LYNNE CANNE·Filed 2011·Granted Jul 30, 2013·60 cites·23 claims
- 0397US8067436B2c-Met modulators and methods of useBANNEN LYNNE CANNE·Filed 2007·Granted Nov 29, 2011·59 cites·4 claims
- 0496US9174947B2c-Met modulators and methods of useBANNEN LYNNE CANNE·Filed 2006·Granted Nov 3, 2015·45 cites·6 claims
- 0596US8476298B2c-Met modulators and method of useBANNEN LYNNE CANNE·Filed 2007·Granted Jul 2, 2013·39 cites·11 claims
- 0696US8178532B2c-Met modulators and method of useBANNEN LYNNE CANNE·Filed 2007·Granted May 15, 2012·46 cites·3 claims
- 0795US11124482B2C-met modulators and methods of useEXELIXIS INC·Filed 2017·Granted Sep 21, 2021·6 cites·11 claims
- 0895US7977345B2c-MET modulators and method of useEXELIXIS INC·Filed 2005·Granted Jul 12, 2011·48 cites·3 claims
- 0990US11219586B2Compositions and methods for delivering cannabinoids to skinAMYRIS INC·Filed 2021·Granted Jan 11, 2022·2 cites·20 claims
- 1089US10695273B2Compositions containing bio-based farnesene or compounds derived therefrom and their use in consumer and industrial productsAMYRIS INC·Filed 2016·Granted Jun 30, 2020·3 cites·23 claims
- 1184US11213467B2Compositions and methods for delivering cannabinoids to skinAMYRIS INC·Filed 2021·Granted Jan 4, 2022·1 cites·28 claims
- 1278US8076338B2Kinase modulators and methods of useANAND NEEL K·Filed 2005·Granted Dec 13, 2011·7 cites·53 claims
- 1375US2020331860A1C-Met Modulators and Methods of UseEXELIXIS INC·Filed 2020·Application pending·0 cites
- 1466US2014155396A1C-Met Modulators and Method of UseEXELIXIS INC·Filed 2013·Application pending·0 cites
- 1566US2014155378A9c-Met Modulators and Method of UseEXELIXIS INC·Filed 2013·Application pending·0 cites
- 1664US2016185725A1c-Met Modulators and Method of UseEXELIXIS INC·Filed 2016·Application pending·0 cites
- 1763US2012184523A1C-Met Modulators and Method of UseBANNEN LYNNE CANNE·Filed 2012·Application pending·0 cites
- 1862US2015376133A1C-Met Modulators and Methods of UseEXELIXIS INC·Filed 2015·Application pending·0 cites
- 1960US2011077233A1C-Met Modulators and Method of UseEXELIXIS INC·Filed 2010·Application pending·0 cites
- 2056US2020390669A1Compositions containing bio-based farnesene or compounds derived therefrom and their use in consumer and industrial productsAMYRIS INC·Filed 2020·Application pending·0 cites
- 2154US2012071513A1Compositions and Their Use as Anti-Tumor AgentsKANNE DAVID·Filed 2011·Application pending·0 cites
- 2253US2008119488A1Modulators Of Nuclear ReceptorsEXELIXIS INC·Filed 2005·Application pending·0 cites
- 2352US2024099950A1Cosmetic compositions and methods of use thereofAMYRIS INC·Filed 2022·Application pending·0 cites
- 2450US2011201599A1CDK ModulatorsEXELIXIS INC·Filed 2009·Application pending·0 cites
- 2550US2010160369A1S1P1 Agonists and Methods of Making And UsingEXELIXIS INC·Filed 2009·Application pending·0 cites
- 2650US2015202196A1Methods of Using C-Met ModulatorsEXELIXIS INC·Filed 2014·Application pending·0 cites
- 2749US2009018145A1Compositions and their use as anti-tumor agentsCOMPASS PHARMACEUTICALS LLC·Filed 2005·Application pending·0 cites
- 2847US2011178087A1Compositions and Their Use as Anti-Tumor AgentsCOMPASS PHARMACEUTICALS LLC·Filed 2011·Application pending·0 cites
- 2947US2022362170A1Compositions and methods for delivering cannabinoids to skinAMYRIS INC·Filed 2020·Application pending·0 cites
- 3047US2023060807A1Antiperspirant formulations comprising hemisqualaneAMYRIS INC·Filed 2020·Application pending·0 cites
- 3144US2012070368A1Methods of Using C-Met ModulatorsBANNEN LYNNE CANNE·Filed 2011·Application pending·0 cites
- 3244US2019054008A1Compositions and methods for extraction of botanical compounds from plantsAMYRIS INC·Filed 2016·Application pending·0 cites
- 3344US2009203577A1Azepinoindole Derivatives As Pharmaceutical AgentsEXELIXIS INC·Filed 2006·Application pending·0 cites
- 3433US2010249071A1Modulators of S1P and Methods of Making And UsingEXELIXIS INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →